Intelligent Investor

Arovella Therapeutics Limited (ASX: ALA) - Announcements

Current share price for ALA : $0.115 0.005 (4.17%)

ASX company news and announcements for Arovella Therapeutics Limited (ALA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Arovella Therapeutics Limited (ALA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Arovella Therapeutics Limited (ALA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Arovella Therapeutics Limited (ALA)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$121 Arovella to present at NWR virtual healthcare conference 19 Mar 2024 10:23AM $0.150 $0.115 $0.115 fallen by 23.33%
$121 Spark Plus Singapore Healthcare Day Presentation 14 Mar 2024 11:16AM $0.155 $0.115 $0.115 fallen by 25.81%
$121 Release of Shares from Escrow 1 Mar 2024 8:35AM $0.165 $0.115 $0.115 fallen by 30.30%
$121 Notice Under Section 708A 29 Feb 2024 10:29AM $0.175 $0.115 $0.115 fallen by 34.29%
$121 Application for quotation of securities - ALA 29 Feb 2024 10:20AM $0.175 $0.115 $0.115 fallen by 34.29%
$121 Appendix 4D and Half Year Report 28 Feb 2024 12:43PM $0.170 $0.115 $0.115 fallen by 32.35%
$121 Notice Under Section 708A 20 Feb 2024 1:21PM $0.180 $0.115 $0.115 fallen by 36.11%
$121 Application for quotation of securities - ALA 20 Feb 2024 1:17PM $0.178 $0.115 $0.115 fallen by 35.21%
$121 Notification regarding unquoted securities - ALA 14 Feb 2024 8:22AM $0.170 $0.115 $0.115 fallen by 32.35%
$121 Proposed issue of securities - ALA 13 Feb 2024 9:18AM $0.180 $0.115 $0.115 fallen by 36.11%
$121 Application for quotation of securities - ALA 31 Jan 2024 4:14PM $0.145 $0.115 $0.115 fallen by 20.69%
$121 Release of Shares from Escrow 31 Jan 2024 3:13PM $0.150 $0.115 $0.115 fallen by 23.33%
$121 Arovella licenses novel CAR-iNKT cell armouring technology 30 Jan 2024 9:57AM $0.130 $0.115 $0.115 fallen by 11.54%
$121 Trading Halt 29 Jan 2024 8:36AM $0.130 $0.115 $0.115 fallen by 11.54%
$121 Quarterly Activities/Appendix 4C Cash Flow Report 25 Jan 2024 12:30PM $0.135 $0.115 $0.115 fallen by 14.81%
$121 Notice Under Section 708A 19 Jan 2024 4:04PM $0.135 $0.115 $0.115 fallen by 14.81%
$121 Application for quotation of securities - ALA 19 Jan 2024 4:00PM $0.135 $0.115 $0.115 fallen by 14.81%
$121 Notice Under Section 708A 16 Jan 2024 5:04PM $0.135 $0.115 $0.115 fallen by 14.81%
$121 Application for quotation of securities - ALA 16 Jan 2024 5:00PM $0.135 $0.115 $0.115 fallen by 14.81%
$121 Notice Under Section 708A 10 Jan 2024 11:17AM $0.135 $0.115 $0.115 fallen by 14.81%
$121 Application for quotation of securities - ALA 10 Jan 2024 10:57AM $0.130 $0.115 $0.115 fallen by 11.54%
$121 Application for quotation of securities - ALA 10 Jan 2024 10:52AM $0.130 $0.115 $0.115 fallen by 11.54%
$121 Proposed issue of securities - ALA 8 Jan 2024 2:23PM $0.125 $0.115 $0.115 fallen by 8%
$121 Notice Under Section 708A 4 Jan 2024 4:35PM $0.120 $0.115 $0.115 fallen by 4.17%
$121 Notification of cessation of securities - ALA 4 Jan 2024 4:34PM $0.120 $0.115 $0.115 fallen by 4.17%

26 - 50 of 429 results

Page 2 of 18

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.